Matta Negri, Haydee del CarmenFlores Rojas, Jackeline Estefany2024-10-182024-10-182024https://hdl.handle.net/20.500.13028/5510Identificar la disponibilidad y precio de los medicamentos esenciales antibacterianos, en la farmacia institucional del Ministerio de Salud, Ica - 2023. Estudio cuantitativo, descriptivo, transversal. Diseño no experimental, al no manipular variables. Muestra censal, el total de los medicamentos esenciales antibacterianos considerados en la RM No 302-2020-MINSA. El estudio no recopiló datos personales de los dependientes o profesionales que laboran en las farmacias institucionales. Técnica, observacional, recetas simuladas. Se indagó por todos los medicamentos antibacterianos considerados en la Resolución ministerial correspondiente, para cada medicamento, se recopilaron datos sobre la disponibilidad y el precio, el periodo de indagación fue el mes de febrero de 2024. Los precios se registraron el día de la indagación, en la ficha de trabajo. Asimismo se cotejaron con fines comparativos los precios reportados por las farmacias privadas y se analizaron los reportes de precios consolidados por DIGEMID en el mismo periodo de tiempo: febrero 2024. Los antibacterianos considerados en la RM disponibles en la farmacia institucional son: Amoxicilina 250 mg/5 mL, líquido oral; Amoxicilina 500 mg, tableta; Azitromicina 500 mg, tableta; Cefalexina 500 mg, tableta; Cefalexina 250mg/5mL, líquido oral y Clindamicina 300 mg, tableta. En líneas generales los precios de los medicamentos en la farmacia institucional son significativamente menores que los precios promedio reportados por las farmacias privadas a nivel de Ica y a nivel nacional. ----- To identify the availability and price of essential antibacterial medications at the institutional pharmacy of the Ministry of Health, Ica - 2023. This was a quantitative, descriptive, cross-sectional study with a nonexperimental design, as it did not manipulate variables. The sample was censal, encompassing the total essential antibacterial medications listed in RM No 302-2020-MINSA. The study did not collect personal data from the staff or professionals working in the institutional pharmacies. The technique was observational, using simulated prescriptions. All antibacterial medications listed in the corresponding ministerial resolution were investigated, and for each medication, data on availability and price were collected during the inquiry period, which was February 2024. Prices were recorded on the day of the inquiry on a work sheet. Additionally, for comparative purposes, the prices reported by private pharmacies were matched and the consolidated price reports by DIGEMID for the same period (February 2024) were analyzed. The antibacterial medications listed in the RM available at the institutional pharmacy were Amoxicillin 250 mg/5 mL oral liquid; Amoxicillin 500 mg tablet; Azithromycin 500 mg tablet; Cephalexin 500 mg tablet; Cephalexin 250 mg/5 mL oral liquid; and Clindamycin 300 mg tablet. Generally, the prices of medications at the institutional pharmacy were significantly lower than the average prices reported by private pharmacies at the Ica level and nationwide.application/pdfspainfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/4.0/Farmacia institucionalAntibacterianosPrecioAvailabilityinfo:eu-repo/semantics/bachelorThesishttps://purl.org/pe-repo/ocde/ford#3.01.05